NONTRAUMA MORTALITY IN ELDERLY WOMEN WITH LOW BONE-MINERAL DENSITY

被引:338
作者
BROWNER, WS
SEELEY, DG
VOGT, TM
CUMMINGS, SR
机构
[1] VET AFFAIRS MED CTR,DEPT MED,GEN INTERNAL MED SECT,SAN FRANCISCO,CA
[2] KAISER PERMANENTE CTR HLTH RES,PORTLAND,OR
[3] UNIV CALIF SAN FRANCISCO,DEPT MED,DIV GEN INTERNAL MED,SAN FRANCISCO,CA 94143
关键词
D O I
10.1016/0140-6736(91)90489-C
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
9704 ambulatory women aged 65 years or older were prospectively studied to determine whether low bone mineral density (osteopenia) was associated with mortality. Bone mineral density was measured at entry to the study by single-photon absorptiometry. 299 women died during a mean of 2.8 years' follow-up. Osteopenia was associated with increased non-trauma mortality, probably because it is a marker for several other adverse factors. Each standard deviation decrease in proximal radius bone mineral density (0.104 g/cm2) was associated with a 1.19-fold increase in mortality (95% confidence interval 1.04-1.36), adjusted for age and duration of follow-up. Diminished bone mineral density at the proximal radius was strongly associated with deaths from stroke (relative risk = 1.74; 95% Cl 1.12-2.70), an association that was not confounded by history of previous stroke, hypertension, postmenopausal use of oestrogen, thiazide diuretic treatment, diabetes mellitus, and smoking. Most deaths in women with low bone mineral density are unrelated to the occurrence of fractures-an observation that should be taken into account when estimating the need for and cost-effectiveness of bone-density screening and fracture prevention programmes.
引用
收藏
页码:355 / 358
页数:4
相关论文
共 31 条
[1]  
AITKEN JM, 1987, OSTEOPOROSIS 1987, P45
[2]   POSTMENOPAUSAL ESTROGEN USE AND HEART-DISEASE RISK-FACTORS IN THE 1980S - RANCHO-BERNARDO, CALIF, REVISITED [J].
BARRETTCONNOR, E ;
WINGARD, DL ;
CRIQUI, MH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 261 (14) :2095-2100
[3]   THE RISK OF BREAST-CANCER AFTER ESTROGEN AND ESTROGEN PROGESTIN REPLACEMENT [J].
BERGKVIST, L ;
ADAMI, HO ;
PERSSON, I ;
HOOVER, R ;
SCHAIRER, C .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (05) :293-297
[4]  
BOHANNON RW, 1986, ARCH PHYS MED REHAB, V67, P390
[5]   CALCITROPIC HORMONES, PLATELET CALCIUM, AND BLOOD-PRESSURE IN ESSENTIAL-HYPERTENSION [J].
BRICKMAN, AS ;
NYBY, MD ;
VONHUNGEN, K ;
EGGENA, P ;
TUCK, ML .
HYPERTENSION, 1990, 16 (05) :515-522
[6]   INJECTION OF 1,25-(OH)2 VITAMIN-D3 ENHANCES RESISTANCE ARTERY CONTRACTILE PROPERTIES [J].
BUKOSKI, RD ;
WANG, D ;
WAGMAN, DW .
HYPERTENSION, 1990, 16 (05) :523-531
[7]   CARDIOVASCULAR MORTALITY AND NONCONTRACEPTIVE USE OF ESTROGEN IN WOMEN - RESULTS FROM THE LIPID RESEARCH CLINICS PROGRAM FOLLOW-UP-STUDY [J].
BUSH, TL ;
BARRETTCONNOR, E ;
COWAN, LD ;
CRIQUI, MH ;
WALLACE, RB ;
SUCHINDRAN, CM ;
TYROLER, HA ;
RIFKIND, BM .
CIRCULATION, 1987, 75 (06) :1102-1109
[8]  
Callaway C.W., 1988, ANTHROPOMETRIC STAND, P39
[9]   THE RELATION OF ENDOGENOUS SEX STEROID-HORMONE CONCENTRATIONS TO SERUM-LIPID AND LIPOPROTEIN LEVELS IN POSTMENOPAUSAL WOMEN [J].
CAULEY, JA ;
GUTAI, JP ;
KULLER, LH ;
POWELL, JG .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1990, 132 (05) :884-894
[10]   HYPERHOMOCYSTEINEMIA - AN INDEPENDENT RISK FACTOR FOR VASCULAR-DISEASE [J].
CLARKE, R ;
DALY, L ;
ROBINSON, K ;
NAUGHTEN, E ;
CAHALANE, S ;
FOWLER, B ;
GRAHAM, I .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (17) :1149-1155